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Proteolytic degradation of the extracellular matrix (ECM) is
one intrinsic property of metastatic tumor cells to breach tis-
sue barriers and to disseminate into different tissues. This
process is initiated by the formation of invadopodia, which
are actin-driven, finger-like membrane protrusions. Yet, little
is known on how invadopodia are endowed with the func-
tional machinery of proteolytic enzymes [1, 2]. The key
protease MT1-MMP (membrane type 1-matrix metalloprotei-
nase) confers proteolytic activity to invadopodia and thus
invasion capacity of cancer cells [3–6]. Here, we report that
MT1-MMP-dependent matrix degradation at invadopodia is
regulated by the v-SNARE TI-VAMP/VAMP7, hence providing
the molecular inventory mediating focal degradative activity
of cancer cells. As observed by TIRF microscopy, MT1-MMP-
mCherry and GFP-VAMP7 were simultaneously detected at
proteolytic sites. Functional ablation of VAMP7 decreased
the ability of breast cancer cells to degrade and invade in
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vadopodia was dramatically decreased in VAMP7- and MT1-
MMP-depleted cells, indicative of a positive-feedback loop in
which the protease as a cargo of VAMP7-targeted transport
vesicles regulates maturation of invadopodia. Collectively,
these data point to a specific role of VAMP7 in delivering
MT1-MMP to sites of degradation, maintaining the functional
machinery required for invasion.
Results and Discussion
MT1-MMP Colocalizes with the v-SNARE VAMP7
at Focal Sites of Degradation
Among the matrix-proteinases, MT1-MMP has been widely
shown to be required for matrix degradation and remodeling
by invasive tumor cells [4, 6–9]. However, the dynamic and co-
ordinated targeting of the transmembrane enzyme MT1-MMP
by cytoplasmic factors to sites of degradation has been sub-
ject of little investigation. It is well established that MT1-
MMP is rapidly endocytosed from the plasma membrane and
reaches early and late endocytic structures ([10], [11], and
our unpublished data). Endocytosis and recycling have been
proposed as a mechanism for controlling MT1-MMP activity
during matrix degradation [10–14], and recently, a Rab8-
dependent pathway was also suggested to contribute to
MT1-MMP exocytosis during collagen degradation [15].
We first set out to explore the subcellular localization of
MT1-MMP, visualized as fluorescently tagged fusion protein
(MT1-MMP-mCherry). MDA-MB-231 human breast cancer
cells stably expressing MT1-MMP-mCherry (MDA-MT1ch
cells, Sakurai-Yageta et al. [16]) were counterstained for
EEA1 (early endosomal antigen 1) and LAMP1 (lysosomal-
associated membrane protein 1), respectively (see Figure S1
available online). The majority of MT1-MMP-mCherry colocal-
ized with the late endosome (LE)/lysosomal compartment
marker LAMP1 (Figure S1B), whereas only few MT1-MMP-
mCherry was found in early endosome (EE) compartments,
as visualized by anti-EEA1 staining (Figure S1A).
It is so far unknown to what extent MT1-MMP trafficking
from EE to LE/lysosomes might represent a degradative path-
way for the protease [10]. Here, we rather wondered whether
this accumulation of MT1-MMP in LE/lysosomal endocom-
partments could also reflect a storage pool that is involved in
active translocation to the plasma membrane. This would re-
quire a specific fusion machinery regulating exocytosis of
these endocompartments. SNARE (soluble NSF [N-ethylmalei-
mide-sensitive factor] attachment protein receptor) proteins
constitute the basic machinery for membrane fusion, thereby
acting in all membrane trafficking steps [17–19]. TI-VAMP/
VAMP7 (referred to as VAMP7 herein) was identified as a vesic-
ular (v-) SNARE mainly present on the TGN (trans-golgi net-
work) and LE/lysosomal structures [20, 21] and was shown
to contribute to neurite outgrowth [22, 23], GLUT4 release
[24], apical targeting in polarized epithelial cells [20, 25],
phagocytosis [26], and cytokinesis [27]. Altogether, these re-
sults led to the conclusion that VAMP7 is the v-SNARE respon-
sible for LE/lysosomal exocytosis (for review, see [28]). VAMP7
staining in MDA-MT1ch cells (Figure 1A) revealed a high
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zation of MT1-MMP to LE/lysosomal structures and raising the
possibility that VAMP7 could regulate the fusion of MT1-MMP-
containing endosomes with the plasma membrane. When
analyzed by live-cell imaging, GFP-VAMP7 and MT1-MMP-
mCherry expressed in MDA-MB-231 cells also displayed
a high degree of colocalization in large static vesicular struc-
tures in the juxtanuclear region of the cells as well as in smaller,
highly dynamic vesicles (Figures 1B and 1B0 and Movie S1).
When MDA-MT1ch cells were plated on fluorescently la-
beled crosslinked gelatin in an assay monitoring matrix degra-
dation [4], regular epifluorescence imaging revealed in rare
cases a weak signal of the protease (MT1-MMP-mCherry,
see Figure 2F) at sites of degradation appearing as black holes
in the fluorescent gelatin (Figure 2C). However, we were unable
to detect GFP-VAMP7 at these sites (Figure 2E). In contrast,
selective illumination of the ventral plasma membrane by
TIRF microscopy showed a strong correlation between MT1-
MMP-mCherry and sites of degradation (compare Figure 2B
with Figure 2C). Furthermore, we found GFP-VAMP7 colocaliz-
ing and accumulating with the protease at the ventral plasma
membrane at focal sites of proteolysis (Figures 2A–2D, 2G,
and 2H). This suggests that although the proteolytic activity re-
sulting in loss of fluorescence of gelatin is mediated by the pro-
tease MT1-MMP, the v-SNARE VAMP7 targets its cargo to fo-
cal sites of degradation. It should be noted that GFP-VAMP7
was neither always detected at (see also Figure 3D) nor re-
stricted to degradative sites (Figure 2D, arrowhead). Because
delivery of cargo is a dynamic process involving recycling of
the fusion machinery, disappearance of the v-SNARE upon fu-
sion by rapid recycling is likely. Moreover, we cannot exclude
that VAMP7 may also transport other cargo(es) different from
MT1-MMP. Nevertheless, the strong colocalization of GFP-
VAMP7 with MT1-MMP-mCherry at sites of degradation
Figure 1. MT1-MMP Is Trafficking in VAMP7-Positive Compartments
(A–A00) MDA-MB-231 cells stably expressing MT1-MMP-mCherry ([A0] and
[A00] in red) were counterstained for VAMP7 ([A] and [A00] in green).
(B) GFP-VAMP7 and MT1-MMP-mCherry are cotrafficking in MDA-MB-231
cells.
(B0) Time lapse of the boxed region in (B). Note that the slight shift of the
mCherry/GFP signals is due to consecutive imaging of GFP-VAMP7 and
MT1-MMP-mCherry (see also Movie S1). Time is given in seconds. The scale
bar in (A00) and in (B) represent 10 mm. The scale bar in (B0) represents 1 mm.
suggests that VAMP7 may be a critical v-SNARE delivering
MT1-MMP to its site of action.
Time-lapse TIRF microscopy of MDA-MB-231 cells express-
ing MT1-MMP-mCherry and GFP-VAMP7 revealed a dynamic
recruitment of GFP-VAMP7 to sites of degradation (Figures
3B–3E). Active sites of degradation were visible by loss of fluo-
rescence of the gelatin (Figure 3C), and these sites corre-
sponded with accumulations of vesicles of GFP-VAMP7 visu-
alized by TIRF (Figures 3B and 3D), indicating that these
vesicles are close to the ventral plasma membrane. Impor-
tantly, recruitment of GFP-VAMP7 vesicles to this site was
observed (Figure 3E, arrow, and Movie S2). Upon dynamic re-
cruitment to this site, these vesicles seemed to dock at this
Figure 2. VAMP7 Colocalizes with MT1-MMP-mCherry at Focal Sites of
Degradation
MDA-MB-231 cells ectopically expressing GFP-VAMP7 (A and E) and MT1-
MMP-mCherry (B and F) on fluorescently labeled gelatin (C) were imaged by
TIRF (A and B) and wide-field (WF) microscopy (E and F). In (D), a merged
image of GFP-VAMP7 in green and MT1-MMP-mCherry in red by TIRF re-
veals a high degree of colocalization of both proteins at the ventral plasma
membrane. The arrowhead points to a GFP-VAMP7 vesicle not colocalizing
with MT1-MMP-mCherry and gelatin degradation. (G) shows enlargements
of the boxed region in (D). In (H), measurements of fluorescent intensities on
the line depicted in (G) on the merged image shows concomitant increase of
intensities of GFP-VAMP7 (green line) and MT1-MMP-mCherry (red line)
correlating with loss of fluorescent intensity of the gelatin (blue line). The
scale bar in (E) (valid for [A]–[F]) represents 5 mm, and the scale bar in (G)
represents 1 mm.
Figure 3. GFP-VAMP7 Is Dynamically Recruited to Active Sites of Proteolysis
GFP-VAMP7 was visualized by wide-field (WF) (A) and TIRF (B) microscopy
in MDA-MB-231 cells coexpressing MT1-MMP-mCherry on fluorescently la-
beled gelatin (C). TIRF microscopy of GFP-VAMP7 (B) reveals small vesicles
close to the ventral plasma membrane, whereas wide-field (A) microscopy
visualizes bigger compartments in the cytoplasm. (D) shows a merged im-
age of GFP-VAMP7 by TIRF (green) and gelatin (red). (E) shows a time lapse
of the boxed region in (D). The arrow indicates movement of a GFP-VAMP7
vesicle toward an accumulation of vesicles marked by an asterisk at sites of
degradation (see also Movie S2). Time is given in seconds. The scale bar in
(B) (valid for [A]–[D]) represents 10 mm; the scale bar in (E) represents 2 mm.
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(A–I0) MDA-MB-231 cells treated with mock (A–C0), VAMP7 (duplexB) (D–F0), and MT1-MMP siRNA (G–I0) were plated on fluorescently labeled gelatin (C, C0, F,
F0, I, and I0) and stained with phalloidin (A, A0, D, D0, G, and G0) and cortactin antibodies (B, B0, E, E0, H, and H0). Enlargements of boxed regions are shown in
(A0), (B0), (C0), (D0), (E0), (F0), (G0), (H0), and (I0) for the corresponding image. The scale bar in (A) (valid for [A], [B], [C], [D], [E], [F], [G], [H], and [I]) represents 10 mm;
the scale bar in (A0) (valid for [A0], [B0], [C0], [D0], [E0], [F0], [G0], [H0], and [I0]) represents 2 mm.
(J) Quantification of gelatin degradation of MDA-MT1ch and MDA-MB-231 cells. Values are means 6 standard errors of means (percentage 6 SEM) of
normalized degradation area.
(K) Results of transwell migration and invasion assay. MDA-MB-231 cells treated with mock and VAMP7 (duplexB) siRNA and mock-treated MDA-MT1ch
cells as indicated were quantified after Transwell migration and invasion through Matrigel. Values are means 6 SEM of normalized percentage.
(L) Resultsof invadopodiaquantification.MDA-MB-231 cellsofsiRNA-treatedpopulations as indicatedwere scored for thepresenceof invadopodia identifiedas
bright actin spots regardless of degradation and further classified according to the number of invadopodia per cell. Values represent means6SEM (percentage).
VAMP7 in MT1-MMP-Mediated Invasion
929place (Figure 3E, asterisk). These nearly immobile vesicles
might represent primed vesicles that are ready to release their
content [29]. Additionally, we observed tubulogenesis from
large GFP-VAMP7- and MT1-MMP-mCherry-positive vesicular
structures in the vicinity of the ventral plasma membrane
(Movie S3), suggesting that transport intermediates were
pinched off from LE/lysosomal compartments for trafficking
of the protease to invadopodia. The high degree of colocaliza-
tion of VAMP7 and MT1-MMP at sites of degradation suggests
an important functional role for VAMP7 in targeted delivery of
the protease underlying the mechanism of MT1-MMP accumu-
lation at invadopodia.
Depletion of VAMP7 Impairs MT1-MMP-Dependent
Degradation and Invasion
We investigated a specific role of VAMP7 for MT1-MMP-de-
pendent ECM proteolysis. First, we analyzed the significance
of MT1-MMP itself for matrix degradation in human cancer
cells. MDA-MB-231 cells were efficiently knocked down with
siRNAs specific to MT1-MMP (Figure S2A), and depletion of
MT1-MMP completely abolished the capacity of these cells
as well as MDA-MT1ch cells to degrade the matrix (Figures
4G–4I0 and 4J, and Figures S2D–S2D00), confirming the para-
mount importance of MT1-MMP in cellular invasiveness [4, 8,
9]. To address the relevance of VAMP7 in MT1-MMP-depen-
dent degradation, we analyzed matrix proteolysis of MDA-
MB-231 and MDA-MT1ch cells depleted for VAMP7. VAMP7
knockdown with two independent siRNAs (Figure S2A) re-
sulted in w60%–70% reduction in the degradative capacity
of MDA-MB-231 cells as compared to mock-treated cells (Fig-
ures 4A–4F0 and 4J and Figures S2B–S2C00). Consistently, even
in the background of stably overexpressed MT1-MMP-
mCherry, depletion of VAMP7 with two different siRNAs in-
hibited matrix degradation to similar extents (Figure 4J).
VAMP7 depletion from MDA-MB-231 cells did neither affect
total protein levels of MT1-MMP (Figure S2E) nor change the
preferential association to LE/lysosomes (data not shown).
This implies that VAMP7 is required for efficient matrix prote-
olysis exerted by endogenous as well as ectopically expressed
MT1-MMP.
To investigate cancer cell invasion through a stiff extracellu-
lar matrix, we compared mock-treated MDA-MB-231 cells with
VAMP7-depleted MDA-MB-231 cells in a Matrigel transwell as-
say as a model of basement-membrane invasion. VAMP7 de-
pletion resulted in a 40% reduced capacity to pass the Matrigel
lattice as compared with mock-treated cells (Figure 4K). Of
note, under similar conditions, MT1-MMP depletion led to
60% inhibition of invasion through Matrigel [16]. Conversely,
stable overexpression of MT1-MMP-mCherry (MDA-MT1ch
cells) increased the invasion capacity to 140% as compared
with mock-treated cells (Figure 4K), confirming previous
results [6, 7, 9]. We then tested the effect of VAMP7 loss of
function on 3D migration in collagen I matrix. Mock and
VAMP7-depleted cells were embedded in collagen I and ana-
lyzed by time-lapse microscopy. As already reported [30],
mock-treated MDA-MB-231 cells displayed mainlya mesenchymal mode of migration (64% mesenchymal versus
36% amoeboid). On the contrary, VAMP7 depletion led to an
inversion of phenotype (42% mesenchymal versus 58% amoe-
boid, see Figures S3A and S3B and Movie S4) and affected nei-
ther speed nor directional persistence of migration (Figure S4).
Altogether, our results are in agreement with recent data
showing that invasion through 3D collagen matrix may be
only partially dependent on pericellular proteolysis and that
cells can switch from mesenchymal to amoeboid movement
upon MMP inhibition [30, 31]. MT1-MMP-mediated pericellular
proteolytic activity is required for cancer cells to breach the
basal membrane and for mesenchymal migration in fibrillar
collagen matrix [6, 9, 31]. Our observations that VAMP7 is
important for both 3D mesenchymal migration in collagen I
and invasion through reconstituted basement membrane as
well as gelatin degradation strongly argue that VAMP7 is a piv-
otal regulator of MT1-MMP-mediated matrix degradation and
invasion.
Invadopodia Formation Is Coupled
to Its Proteolytic Machinery
Analysis of the structural components required for invadopo-
dia formation revealed several components such as N-
WASP, Arp2/3 complex, and cortactin, which constitute the
actin polymerization machinery. Signaling molecules such as
c-Src orchestrate the formation of invadopodia (for review,
see [32]). Interestingly, it has been proposed recently that
MT1-MMP expression and activity are required for formation
and maturation of invadopodia in SCC61 squamous cell carci-
noma and MDA-MB-231 cell lines [3, 4]. Thus, we wondered
whether impairment of MT1-MMP exocytosis by VAMP7 de-
pletion affected formation of invadopodia. We analyzed inva-
dopodia formation in MDA-MB-231 cells plated on fluores-
cently labeled matrix, stained for filamentous actin and
cortactin [3, 4]. In mock-treated cells, we readily observed
invadopodia in which F-actin and cortactin staining perfectly
colocalized (Figures 4A–4B0). In some instances, the gelatin
degradation was even broader (Figures 4C and 4C0), corre-
sponding to previous sites of proteolytic degradation no lon-
ger associated with invadopodia as described [33]. Notably,
the intensity and number of F-actin and cortactin doubly
stained structures was decreased in VAMP7-depleted cells
(Figures 4D–4E0), and these were associated with reduced pro-
teolysis of the underlying matrix (Figures 4F and 4F0). In MT1-
MMP-depleted cells, invadopodia were strongly reduced (Fig-
ures 4G–4H0), and matrix proteolysis was abolished (Figures 4I
and 4I0; see also Figures S2B–S2D00). Quantification of invado-
podia resulted in 19% of mock-treated cells displaying invado-
podia, whereas this number was reduced to 8%–9% in
VAMP7-depleted cells and less than 5% of MT1-MMP-
siRNA-treated cells (Figure 4L). The number of invadopodia
per cell was greatly reduced in VAMP7 cells, although not as
strongly affected as in MT1-MMP-siRNA-treated cells (Fig-
ure 4L). Strikingly, VAMP7-depleted cells showed reduced
amount of surface MT1-MMP clusters at the extracellular site
of invadopodia, although total MT1-MMP levels were not(M–P0) MDA-MB-231 cells treated with mock (M–N0) or VAMP7 siRNA (duplexB) (O–P0) were subjected to surface labeling with MT1-MMP antibodies. Enlarge-
ments of regions boxed in (M) and (O) are shown in (M0), (N0), (O0), and (P0) for thecorresponding image.Thescalebar in (M) (valid for [M], [N], [O],and [P]) represents
10 mm, and the scale bar in (M0) (valid for [M0], [N0], [O0], and [P0]) represents 2 mm.
(Q) Quantification of surface MT1-MMP accumulation. MDA-MB-231 cells of siRNA-treated populations as indicated were scored for the presence of surface
MT1-MMP clusters at the ventral plasmamembrane incontact with thematrix, regardless of degradation. Values represent mean percentage6SEM. Differences
between all siRNA-treated populations and respective mock populations from all quantifications were confirmed to be statistically significant (see Table S1). The
number of experiments (N) and total number of cells (n) are indicated.
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treated cells showed MT1-MMP accumulations at the ventral
plasma membrane versus 5%–8% in VAMP7-siRNA-treated
cells, Figure 4Q). Altogether, the data presented here strongly
argue for VAMP7 being a critical SNARE during directed deliv-
ery of MT1-MMP to invadopodia. Furthermore, our findings
that prevention of MT1-MMP delivery (VAMP7 siRNA) or ex-
pression (MT1-MMP siRNA) led to reduced invadopodia
number agree with recent reports suggesting that MT1-MMP
contributes to invadopodia formation and/or maturation
[3, 4]; i.e., invadopodia formation in VAMP7-depleted cells is
blocked or arrested in a premature state, at which accumula-
tion of the protease is blocked.
The paramount importance of MT1-MMP for cancer cell in-
vasion is well documented [7–9]. We addressed here the ques-
tion of how the protease is localized to sites of matrix proteol-
ysis and connect for the first time a v-SNARE to its cargo MT1-
MMP. VAMP7 and MT1-MMP are colocalized at proteolytic
sites; furthermore, depletion of VAMP7 phenocopied partially
the effect of MT1-MMP depletion from cancer cells, leading
to reduced degradative and invasive capacities. Strikingly, si-
lencing of VAMP7 resulted in a reduced invadopodia number,
which was accompanied by significantly lesser amounts of
MT1-MMP accumulated at the ventral side of the cells facing
the ECM. Finally, loss of VAMP7 resulted in a switch from mes-
enchymal to amoeboid mode of migration. Altogether, these
data identify VAMP7 as a key cellular factor necessary for
MT1-MMP-dependent matrix degradation, suggesting LE/ly-
sosomal exocytosis to be an important process for matrix deg-
radation by tumor cells. Beyond its relevance for signaling
leading to known consequences for actin polymerization at in-
vadopodia, our study pinpoints membrane trafficking as an es-
sential component of the mechanisms of invadopodia forma-
tion and activity.
Supplemental Data
Experimental Procedures, four figures, one table, and four movies are avail-
able at http://www.current-biology.com/cgi/content/full/18/12/926/DC1/.
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